Argument (#04 April 2014)

Biosimilars Trying to Enter the Ukrainian Market

by Evgenia V. Paliy

The past few decades have seen a real breakthrough in the field of biotechnology, which is being increasingly used in various fields, but especially in medicine. Patents for exclusive marketing of a number of original biotech drugs are expected to expire within the next few years. This provides an opportunity for manufacturing and development of biosimilars — official copies, reproduced of biotech medicinal products…

The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.

Please send subscription inquiries by:

Fax: +380 44 495-2777
E-mail: subscribe@ujbl.info

Subscribe
The Ukrainian Journal of Business Law

Subscribe to The Ukrainian Journal of Business Law right now and enjoy the most relevant issues on doing business in Ukraine on your device or in print.

All this for just USD 9.99 a month.

 

Subscribe now

Яндекс.Метрика